Dihydroergotamine Mesylate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

Company

DUNS: 001230762

Effective Date

March 17, 2023

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NDC Product Code

0143-9151

Application Number

ANDA040453

Marketing Category

ANDA (C73584)

Route of Administration

INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

Effective Date

March 17, 2023

Ingredients

Code: 81AXN7R2QTClass: ACTIBQuantity: 1 mg in 1 mL

GLYCERINInactive

Code: PDC6A3C0OXClass: IACT

ALCOHOLInactive

Code: 3K9958V90MClass: IACT

SODIUM HYDROXIDEInactive

Code: 55X04QC32IClass: IACT

METHANESULFONIC ACIDInactive

Code: 12EH9M7279Class: IACT

WATERInactive

Code: 059QF0KO0RClass: IACT